The "Make America Healthy Again" movement notched a big win on pesticide regulation during Thursday's debate on a House farm bill, only to see the White House pull the nomination of a favored influencer for surgeon general hours later.
Why it matters: The events showed how the movement continues to have clout on matters related to the food supply, but can be a political liability when it comes to vaccines and other public health matters.
The AI industry has entered an era of perpetual upheaval where market leaders are crowned — and dethroned — every few months.
Today's hottest company could be eclipsed by summer and the laggard could revolutionize the world.
Why it matters: As AI changes everything, keeping up with who's dominant and who's falling behind is becoming an existential question for investors, big businesses and regular users trying to guarantee their own futures.
Rocsys unveiled a robotic, multi-bay charging system Wednesday that can manage up to 10 robotaxis at once.
Why it matters: As robotaxis proliferate, infrastructure — including charging — could become a critical bottleneck for efficient large-scale fleet operations, making automation a no-brainer.
The Food and Drug Administration on Tuesday kicked off an effort to use AI and other data science tools to monitor clinical trials in real time and cut down review times for new drugs.
Why it matters: Agency leaders portrayed the move as a major step toward keeping U.S. biomedical research competitive against countries like China.
